Clinical application of percutaneous pulmonary valve implantation in patients with pulmonary valve regurgitation
10.3760/cma.j.cn101070-20200308-00349
- VernacularTitle:经皮肺动脉瓣植入术在肺动脉瓣反流患者中的临床应用
- Author:
Dong LIANG
1
;
Maozheng XUAN
;
Jiangzhen LI
;
Taibing FAN
Author Information
1. 河南省人民医院，阜外华中心血管医院，郑州大学人民医院心血管外科 450000
- From:
Chinese Journal of Applied Clinical Pediatrics
2020;35(4):318-320
- CountryChina
- Language:Chinese
-
Abstract:
Percutaneous pulmonary valve implantation (PPVI) is applied relatively late in clinical practice in China as an emerging technology, but it has developed rapidly with the increasing clinical attention paid to severe pulmonary valve regurgitation in medical level in China and the clinical appearance of congenital heart disease patients with right ventricular outflow obstruction after surgery.In the past ten years, European and American countries have applied PPVI in clinical practice, which has the advantages of minimally invasive, reproducibility and good postoperative efficacy compared with traditional surgery.The clinical application of PPVI in patients with pulmonary regurgitation is summarized.
